Dnternexin, a Novel Neuronal Intermediate Filament Protein, Precedes the Low Molecular Weight Neurofilament Protein (NF-L) in the Developing Rat Brain

Total Page:16

File Type:pdf, Size:1020Kb

Dnternexin, a Novel Neuronal Intermediate Filament Protein, Precedes the Low Molecular Weight Neurofilament Protein (NF-L) in the Developing Rat Brain The Journal of Neuroscience, August 1990, W(8): 2735-2748 dnternexin, a Novel Neuronal Intermediate Filament Protein, Precedes the Low Molecular Weight Neurofilament Protein (NF-L) in the Developing Rat Brain Michael P. Kaplan, Steven S. M. Chin, Karsten H. Fliegner, and Ronald K. H. Liem DeDartments of Patholoav and Anatomv and Cell Bioloav, Columbia University College of Physicians and Surgeons, New Yolk, New York 10032 -’ cr-lnternexin is a 66 kDa protein that copurifies with inter- rons in the central and peripheral nervous system. A fourth mediate filaments (IF) from rat spinal cord and optic nerve. neuronal intermediate filament protein has recently been de- This protein is axonally transported in rat optic nerve along scribed (Portier et al., 1984; Parysek and Goldman, 1987; Leon- with the neurofilament triplet proteins in slow component a. ard et al., 1988); termed “peripherin,” this 57 kDa protein is Polymerization in vitro and distribution in viva confirm that found primarily in processesof the peripheral nervous system. cr-internexin is a neuronal IF. We raised 2 highly specific While their exact functions remain unclear, neuronal IFS pre- monoclonal antibodies to a-internexin which were applied sumably play some structural role in the generation and/or to frozen rat brain sections and Western blots of cytoskeletal maintenance of the highly asymmetrical forms of neurons and extracts. These results indicate that cY-internexin is primarily their processes;for example, it has been suggestedthat neuronal an axonal protein found in most, if not all, neurons of the IFS may be arbiters of neuronal caliber (for review, seeLasek CNS. lmmunoreactive proteins of similar molecular weight et al., 1983). were found in cytoskeletal extracts of CNS tissue from sev- Like other IFS, such as glial fibrillary acidic protein (GFA) in eral additional species, including mouse and cow. While the astroglia, desmin in smooth musclecells, and vimentin in cells distribution of cr-internexin as given by immunocytochemical of mesenchymalorigin, the neuronal IF proteins each contain methods is similar to that of low molecular weight neurofila- a highly conserved a-helical domain, flanked by variable head ment protein (NF-L) in the adult, its distribution in the embryo and tail sequences(for review, see Steinert and Roop, 1988); is far more extensive. At embryonic day 16, when the expres- the rod-shaped,a-helical domains form the core of the filament, sion of NF-L is still limited to a relatively small number of with the variable end sequencesprojecting outward. The exten- cells and levels of expression are low, a-internexin is already sive carboxy-terminal end sequenceof NF-H is known to par- found at much higher levels and in cells not yet expressing ticipate in the formation of cross-bridgesbetween filaments (Hi- NF-L in detectable quantities. Similar results are found at rokawa et al., 1984). NF-L, but not NF-M or NF-H, is readily embryonic day 12. These data suggest that neuronal IF in able to self-polymerize in vitro at physiological pH (Liem and the developing nervous system contain a higher proportion Hutchison, 1982); inability of the other isolated subunits to of cu-internexin than their adult counterparts, and that expres- polymerize is probably due to ionic repulsion between their sion of cY-internexin precedes that of NF-L in many or most highly phosphorylated tail sequences,and it has recently been neurons of the developing brain. suggestedthat this repulsion between phosphate groups may play a role in maintaining the distance between filaments in vivo Mammalian neuronal intermediate filaments (IF) have long been (Hirokawa et al., 1984; Carden et al., 1987; Shaw, in press). describedin terms of a “neurofilament triplet” of low, medium, Developmental studiesusing biochemical and immunological and high molecular weight proteins, designatedNF-L, NF-M, methods have shown that neurogenesisis accompanied by and NF-H, respectively (Hoffman and Lasek, 1975; Liem et al., changesin neuronal IF composition. After an initial stageduring 1978). Insoluble at physiological pH, they polymerize in vivo to which vimentin may be expressed(Bignami et al., 1982; Co- form 10 nm IFS which traverse the length of the neuronal axo- chard and Paulin, 1984), coexpressionof NF-L and NF-M pre- plasm. Filaments composed of variable proportions of the 3 cedesthat of NF-H in developing rat brain (Shaw and Weber, neurofilament proteins can be detected in the axons (and, to a 1982; Carden et al., 1987) retina (Shaw and Weber, 1983), and lesserextent, the dendrites and perikarya) of most mature neu- optic nerve (Pachter and Liem, 1984). Neuronal IFS containing NF-L and NF-M can be detected as early as embryonic day 12 Received March 7, 1990; revised April 24, 1990; accepted April 25, 1990. in some regions, while NF-H may not be expresseduntil days We thank Dr. James Goldman and Dr. John Pintar for their expert advice on or weeksafter birth in some areas. Hippocampal neurons cul- developmental anatomy, Mr. David Weinstein and Mr. Ray Manson for photo- tured in vitro display a similar stepwisepattern of expression graphic work, and Ms. Kristy Brown for electron microscopy. This work was (Shaw et al., 1985). The significanceof this delayed appearance supported by Grants NS 15 182 (Jacob Javits Neuroscience Award) and EY03849. K.H.F. and S.S.M.C. are supported by a Medical Scientist Training Program Grant of the larger subunit is probably related to its putative role as at New York University School of Medicine. cross-linker between filaments and the stabilization of IF struc- Correspondence should be addressed to Dr. Ronald K. H. Liem, Department of Pathology, Columbia University College of Physicians and Surgeons, 630 West ture presumably accompanying neuronal maturation. In the pe- 168th Street, New York, NY 10032. ripheral nervous system, this scenariois further complicated by Copyright 0 1990 Society for Neuroscience 0270-6474/90/082735-14$03.00/O the presenceof peripherin, which appearsaround the sametime 2736 Kaplan et al. * dnternexin, a Neuronal IF in the Developing CNS Figure 1. oc-Internexinis an interme- diatefilament protein. a-Intemexin was purifiedfrom a T&on-insoluble,IF-en- riched extract (lane a) by successive hydroxylapatiteand DEAE chromatog- raphyin 8 M urea.The purified material (laneb) readilyformed 10 nm filaments :t uponremoval of the urea, as shown by electronmicroscopy, mag. 113,400x (lanec). cu-Intemexin(I) appearsin cy- Gbf toskeletalextracts as a majorband mi- gratingbelow NF-L, with an apparent molecularweight of 66 kDa; other ma- jor bandsin the extractinclude the pro- teinsofthe neurofilamenttriplet, NF-H (H), NF-M (M), and NF-L (L), aswell asglial filamentprotein, GFA (G). a as NF-M in development (Troy et al., 1990). Unlike the neu- A) containing 0.85 M sucrose and 1 .O% Triton X-100. Unless otherwise rofilament triplet proteins, however, peripherin is up-regulated noted, inhibitors and reagents were obtained from the Sigma Chemical Co. (St. Louis, MO). Homogenates were incubated for 1 hr on ice in following axotomy (Oblinger et al., 1989), suggestingsome role the presence of 0.5 &/ml DNAse I (Boehringer Mannheim, Indianap- for this protein in axon outgrowth. olis. IM and centrifuaed for 5 min at 10.000mm to uelletthe insoluble Apparently, the concept of a “neurofilament triplet” in the filaments. Pellets were washed twice by resuspension in w 10 vol of central nervous system (CNS) may also stand in need of some solution A followed by centrifugation as before. Final pellets were ho- mogenized in approximately equal volumes of either deionized 8 M urea revision. cr-Internexin is a 66 kDa protein that copurifies with or sample buffer (0.0625 mM Tris buffer, pH 6.5, 10% (voVvo1) glycerol, IFS from rat brain, spinal cord, and optic nerve (Pachter and 1% (vol/vol) ,&mercaptoethanol, 1% (vol/vol) sodium dodecyl sulfate, Liem, 1985). Data presentedhere, including polymerization in 0.1% bromophenol blue), and stored at -20°C. vitro, distribution in vivo, and axonal transport, demonstrate Purification and reassembly of Lu-internexin. cu-Intemexin was purified that a-internexin is a neuronal IF protein presentin a wide range from cytoskeletal extracts of rat spinal cord by successive hydroxylapa- tite and DEAE-cellulose chromatography in the presence of 8 M urea, ofmammalian species.These and other data, including sequence as described previously (Pachter and Liem, 1985). For reassembly of analysisof a cDNA clone, conducted in our laboratory (F’liegner purified o-intemexin, urea was removed by dialysis and insoluble ma- et al., 1990)confirm the identity of a-internexin and the “novel terial was pelleted by centrifugation at 100,000 x g for 60 min. Pellets 66 kD NF protein” describedby Chiu et al. (1989). While the were fixed in 1% glutaraldehyde, embedded in plastic resin, sectioned on a Sorvall MT5000 ultramicrotome, and stained with uranyl acetate distribution of ol-internexin in the adult closely parallelsthat of and Reynolds lead citrate for conventional transmission electron mi- the neurofilament triplet proteins, its distribution in the embryo croscopy (Reynolds, 1963). Sections were viewed on a JEOL 1OOC is far more extensive, approaching adult patterns and levels of electron microscope operating at 80 kV. expressionat an earlier age, around embryonic day 16. Im- Antibodies. Two monoclonal antibodies recognizing cu-intemexin, munological and biochemical data presentedhere suggestthat mAb 135 and mAb233, were obtained, according to the method of Koh- ler and Milstein (1976), from 2 separate fusions in the presence of embryonic neuronal IFS contain a higher proportion of cu-in- polyethylene glycol (Gibco Laboratories, Grand Island, NY) of NS-1 ternexin than their adult counterparts, and that the expression mouse myeloma cells with spleen cells from Balb/c mice previously of cy-internexinprecedes that of NF-L in most of the developing immunized with purified ol-internexin.
Recommended publications
  • Blood Neurofilament Light Chain: the Neurologist's Troponin?
    biomedicines Review Blood Neurofilament Light Chain: The Neurologist’s Troponin? Simon Thebault 1,*, Ronald A. Booth 2 and Mark S. Freedman 1,* 1 Department of Medicine and the Ottawa Hospital Research Institute, The University of Ottawa, Ottawa, ON K1H8L6, Canada 2 Department of Pathology and Laboratory Medicine, Eastern Ontario Regional Laboratory Association and Ottawa Hospital Research Institute, University of Ottawa & The Ottawa Hospital, Ottawa, ON K1H8L6, Canada; [email protected] * Correspondence: [email protected] (S.T.); [email protected] (M.S.F.) Received: 4 November 2020; Accepted: 18 November 2020; Published: 21 November 2020 Abstract: Blood neurofilament light chain (NfL) is a marker of neuro-axonal injury showing promising associations with outcomes of interest in several neurological conditions. Although initially discovered and investigated in the cerebrospinal fluid (CSF), the recent development of ultrasensitive digital immunoassay technologies has enabled reliable detection in serum/plasma, obviating the need for invasive lumbar punctures for longitudinal assessment. The most evidence for utility relates to multiple sclerosis (MS) where it serves as an objective measure of both the inflammatory and degenerative pathologies that characterise this disease. In this review, we summarise the physiology and pathophysiology of neurofilaments before focusing on the technological advancements that have enabled reliable quantification of NfL in blood. As the test case for clinical translation, we then highlight important recent developments linking blood NfL levels to outcomes in MS and the next steps to be overcome before this test is adopted on a routine clinical basis. Keywords: neurofilament light chain; biomarkers; multiple sclerosis 1. Neurofilament Structure and Function Neurofilaments are neuronal-specific heteropolymers conventionally considered to consist of a triplet of light (NfL), medium (NfM) and heavy (NfH) chains according to their molecular mass [1].
    [Show full text]
  • Immunological Properties and Cdna Sequence Analysis of an Intermediate-filament-Like Protein from Squid Neuronal Tissue
    Journal of Cell Science 106, 1283-1290 (1993) 1283 Printed in Great Britain © The Company of Biologists Limited 1993 Immunological properties and cDNA sequence analysis of an intermediate-filament-like protein from squid neuronal tissue James Adjaye*, Philip J. Marsh and Peter A. M. Eagles† Department of Molecular Biology and Biophysics, The Randall Institute, King’s College London, 26-29 Drury Lane, London WC2B 5RL, UK *Present address: Max-Planck-Institute for Biophysical Chemistry, Department of Biochemistry, PO Box 2841, D-3400, Goettingen, FRG †Author for correspondence SUMMARY A cDNA library has been constructed in the expression (IF) proteins. The rod has the classical heptad repeats vector gt11 from mRNA isolated from squid (Loligo indicating coiled-coil-forming ability, and the predicted forbesi) optic lobes. The library was screened with anti- lengths of the coils are similar to coils 1a, 1b and 2 of bodies generated against purified squid neurofilaments. intermediate filaments. At the C-terminal end of the rod A positive clone was isolated, which harboured a gt11 there is a strongly conserved IF epitope, and a fusion recombinant having an insert size of 3.5 kb. Hybridiz- protein containing SNLK is recognised by the pan- ation analysis by Southern and northern blotting specific intermediate filament antibody, IFA. A poly- showed that the corresponding protein is encoded by a clonal antibody raised against SNLK has been used to single gene that gives rise to a transcript of 2.6 kb. show that the protein is present only in neuronal tissues Translation of the full nucleotide sequence of the gene and that it is immunologically related to neurofilaments revealed an open reading frame covering 557 amino from Myxicola but not from mammals.
    [Show full text]
  • Neurofilaments: Neurobiological Foundations for Biomarker Applications
    Neurofilaments: neurobiological foundations for biomarker applications Arie R. Gafson1, Nicolas R. Barthelmy2*, Pascale Bomont3*, Roxana O. Carare4*, Heather D. Durham5*, Jean-Pierre Julien6,7*, Jens Kuhle8*, David Leppert8*, Ralph A. Nixon9,10,11,12*, Roy Weller4*, Henrik Zetterberg13,14,15,16*, Paul M. Matthews1,17 1 Department of Brain Sciences, Imperial College, London, UK 2 Department of Neurology, Washington University School of Medicine, St Louis, MO, USA 3 a ATIP-Avenir team, INM, INSERM , Montpellier university , Montpellier , France. 4 Clinical Neurosciences, Faculty of Medicine, University of Southampton, Southampton General Hospital, Southampton, United Kingdom 5 Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, Québec, Canada 6 Department of Psychiatry and Neuroscience, Laval University, Quebec, Canada. 7 CERVO Brain Research Center, 2601 Chemin de la Canardière, Québec, QC, G1J 2G3, Canada 8 Neurologic Clinic and Policlinic, Departments of Medicine, Biomedicine and Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland. 9 Center for Dementia Research, Nathan Kline Institute, Orangeburg, NY, 10962, USA. 10Departments of Psychiatry, New York University School of Medicine, New York, NY, 10016, 11 Neuroscience Institute, New York University School of Medicine, New York, NY, 10016, USA. 12Department of Cell Biology, New York University School of Medicine, New York, NY, 10016, USA 13 University College London Queen Square Institute of Neurology, London, UK 14 UK Dementia Research Institute at University College London 15 Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden 16 Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden 17 UK Dementia Research Institute at Imperial College, London * Co-authors ordered alphabetically Address for correspondence: Prof.
    [Show full text]
  • Intermediate Filament Accumulation Can Stabilize Microtubules in Caenorhabditis Elegans Motor Neurons
    Intermediate filament accumulation can stabilize microtubules in Caenorhabditis elegans motor neurons Naina Kurupa, Yunbo Lia, Alexandr Goncharova, and Yishi Jina,b,1 aNeurobiology Section, Division of Biological Sciences, University of California, San Diego, La Jolla, CA 92093; and bDepartment of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA 92093 Edited by H. Robert Horvitz, Massachusetts Institute of Technology, Cambridge, MA, and approved February 11, 2018 (received for review December 21, 2017) Neural circuits utilize a coordinated cellular machinery to form and Results eliminate synaptic connections, with the neuronal cytoskeleton Identification of IF Genes That Regulate Synapse Rewiring. At the playing a prominent role. During larval development of Caenorhabditis end of larval stage 1 (L1), the dorsal D (DD)-type motor neurons elegans, synapses of motor neurons are stereotypically rewired rewire their presynaptic connections from the ventral nerve cord through a process facilitated by dynamic microtubules (MTs). Through a (VNC) to the dorsal nerve cord (DNC), concurrent with the genetic suppressor screen on mutant animals that fail to rewire synap- birth of ventral D (VD)-type motor neurons, which then form ses, and in combination with live imaging and ultrastructural studies, synapses along the VNC (19). We visualized DD-neuron pre- we find that intermediate filaments (IFs) stabilize MTs to prevent syn- synaptic terminals using a GFP-tagged synaptobrevin (SNB- apse rewiring. Genetic ablation of IFs or pharmacological disruption of 1::GFP) reporter (juIs137:Pflp-13 SNB-1::GFP). In L1 animals, IF networks restores MT growth and rescues synapse rewiring defects discrete synaptic puncta were present along the ventral neurites in the mutant animals, indicating that IF accumulation directly alters MT (18), but in late larvae and adults, synaptic puncta were only seen stability.
    [Show full text]
  • Attenuated Neurodegenerative Disease Phenotype in Tau Transgenic Mouse Lacking Neurofilaments
    The Journal of Neuroscience, August 15, 2001, 21(16):6026–6035 Attenuated Neurodegenerative Disease Phenotype in Tau Transgenic Mouse Lacking Neurofilaments Takeshi Ishihara, Makoto Higuchi, Bin Zhang, Yasumasa Yoshiyama, Ming Hong, John Q. Trojanowski, and Virginia M.-Y. Lee Center for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104 Previous studies have shown that transgenic (Tg) mice overex- particular NFL, resulted in a dramatic decrease in the total pressing human tau protein develop filamentous tau aggre- number of tau-positive spheroids in spinal cord and brainstem. gates in the CNS. The most abundant tau aggregates are found Concomitant with the reduction in spheroid number, the bigenic in spinal cord and brainstem in which they colocalize with mice showed delayed accumulation of insoluble tau protein in neurofilaments (NFs) as spheroids in axons. To elucidate the the CNS, increased viability, reduced weight loss, and improved role of NF subunit proteins in tau aggregate formation and to behavioral phenotype when compared with the single T44 Tg test the hypothesis that NFs are pathological chaperones in the mice. These results imply that NFs are pathological chaperones formation of intraneuronal tau inclusions, we crossbred previ- in the development of tau spheroids and suggest a role for NFs ously described tau (T44) Tg mice overexpressing the smallest in the pathogenesis of neurofibrillary tau lesions in neurodegen-
    [Show full text]
  • Neurofilaments and Neurofilament Proteins in Health and Disease
    Downloaded from http://cshperspectives.cshlp.org/ on October 5, 2021 - Published by Cold Spring Harbor Laboratory Press Neurofilaments and Neurofilament Proteins in Health and Disease Aidong Yuan,1,2 Mala V. Rao,1,2 Veeranna,1,2 and Ralph A. Nixon1,2,3 1Center for Dementia Research, Nathan Kline Institute, Orangeburg, New York 10962 2Department of Psychiatry, New York University School of Medicine, New York, New York 10016 3Cell Biology, New York University School of Medicine, New York, New York 10016 Correspondence: [email protected], [email protected] SUMMARY Neurofilaments (NFs) are unique among tissue-specific classes of intermediate filaments (IFs) in being heteropolymers composed of four subunits (NF-L [neurofilament light]; NF-M [neuro- filament middle]; NF-H [neurofilament heavy]; and a-internexin or peripherin), each having different domain structures and functions. Here, we review how NFs provide structural support for the highly asymmetric geometries of neurons and, especially, for the marked radial expan- sion of myelinated axons crucial for effective nerve conduction velocity. NFs in axons exten- sively cross-bridge and interconnect with other non-IF components of the cytoskeleton, including microtubules, actin filaments, and other fibrous cytoskeletal elements, to establish a regionallyspecialized networkthat undergoes exceptionallyslow local turnoverand serves as a docking platform to organize other organelles and proteins. We also discuss how a small pool of oligomeric and short filamentous precursors in the slow phase of axonal transport maintains this network. A complex pattern of phosphorylation and dephosphorylation events on each subunit modulates filament assembly, turnover, and organization within the axonal cytoskel- eton. Multiple factors, and especially turnover rate, determine the size of the network, which can vary substantially along the axon.
    [Show full text]
  • The Role of Tau in Amyloid Β Plaque Growth and Formation
    THE ROLE OF TAU IN AMYLOID β PLAQUE GROWTH AND FORMATION Dissertation zur Erlangung des naturwissenschaftlichen Doktorgrades an der Fakultät für Biologie der Ludwig-Maximilians-Universität München vorgelegt von Hazal Salihoglu München, den 07.06.2019 i Neyi arıyorsan O’sun sen. What you seek is seeking you. Was du suchst, sucht dich. Mevlana (1207-1273) i Diese Dissertation wurde unter der Leitung von Prof. Dr. Jochen Herms am Institut für Neuropathologie der Ludwig-Maximilians-Universität angefertigt und von Prof. Dr. Wolfgang Enard an der Fakultät für Biologie vertreten. Eidesstattliche Erklärung Ich versichere hiermit an Eides statt, dass die vorgelegte Dissertation von mir selbständig und ohne unerlaubte Hilfe angefertigt ist. Hiermit erkläre ich, dass die Dissertation nicht ganz oder in wesentlichen Teilen einer anderen Prüfungskommission vorgelegt worden ist und ich mich anderweitig einer Doktorprüfung ohne Erfolg nicht unterzogen habe. München, den 17.10.2018 Hazal Salihoglu Erstgutachter: Prof. Dr. Wolfgang Enard Zweitgutachter: Dr. rer. nat. Anja Horn-Bochtler Tag der Abgabe: 06.11.2018 Tag der mündlichen Prüfung: 27.05.19 ii Table of contents Table of Contents ACKNOWLEDGEMENTS .................................................................................................... 1 DECLARATION ................................................................................................................... 2 LIST OF FIGURES ..............................................................................................................
    [Show full text]
  • Cytoskeletal Proteins in Neurological Disorders
    cells Review Much More Than a Scaffold: Cytoskeletal Proteins in Neurological Disorders Diana C. Muñoz-Lasso 1 , Carlos Romá-Mateo 2,3,4, Federico V. Pallardó 2,3,4 and Pilar Gonzalez-Cabo 2,3,4,* 1 Department of Oncogenomics, Academic Medical Center, 1105 AZ Amsterdam, The Netherlands; [email protected] 2 Department of Physiology, Faculty of Medicine and Dentistry. University of Valencia-INCLIVA, 46010 Valencia, Spain; [email protected] (C.R.-M.); [email protected] (F.V.P.) 3 CIBER de Enfermedades Raras (CIBERER), 46010 Valencia, Spain 4 Associated Unit for Rare Diseases INCLIVA-CIPF, 46010 Valencia, Spain * Correspondence: [email protected]; Tel.: +34-963-395-036 Received: 10 December 2019; Accepted: 29 January 2020; Published: 4 February 2020 Abstract: Recent observations related to the structure of the cytoskeleton in neurons and novel cytoskeletal abnormalities involved in the pathophysiology of some neurological diseases are changing our view on the function of the cytoskeletal proteins in the nervous system. These efforts allow a better understanding of the molecular mechanisms underlying neurological diseases and allow us to see beyond our current knowledge for the development of new treatments. The neuronal cytoskeleton can be described as an organelle formed by the three-dimensional lattice of the three main families of filaments: actin filaments, microtubules, and neurofilaments. This organelle organizes well-defined structures within neurons (cell bodies and axons), which allow their proper development and function through life. Here, we will provide an overview of both the basic and novel concepts related to those cytoskeletal proteins, which are emerging as potential targets in the study of the pathophysiological mechanisms underlying neurological disorders.
    [Show full text]
  • Specialized Roles of Neurofilament Proteins in Synapses
    Brain Research Bulletin 126 (2016) 334–346 Contents lists available at ScienceDirect Brain Research Bulletin j ournal homepage: www.elsevier.com/locate/brainresbull Review Specialized roles of neurofilament proteins in synapses: Relevance to neuropsychiatric disorders a,b,∗ a,b,c,∗ Aidong Yuan , Ralph A. Nixon a Center for Dementia Research, Nathan Kline Institute, Orangeburg, New York, 10962, United States b Departments of Psychiatry, New York University School of Medicine, New York, NY, 10016, United States c Department of Cell Biology, New York University School of Medicine, New York, NY, 10016, United States a r t i c l e i n f o a b s t r a c t Article history: Neurofilaments are uniquely complex among classes of intermediate filaments in being composed of four Received 11 July 2016 subunits (NFL, NFM, NFH and alpha-internexin in the CNS) that differ in structure, regulation, and func- Received in revised form 2 September 2016 tion. Although neurofilaments have been traditionally viewed as axonal structural components, recent Accepted 3 September 2016 evidence has revealed that distinctive assemblies of neurofilament subunits are integral components Available online 5 September 2016 of synapses, especially at postsynaptic sites. Within the synaptic compartment, the individual subunits differentially modulate neurotransmission and behavior through interactions with specific neurotrans- Keywords: mitter receptors. These newly uncovered functions suggest that alterations of neurofilament proteins Neurofilament subunit Synapse not only underlie axonopathy in various neurological disorders but also may play vital roles in cog- nition and neuropsychiatric diseases. Here, we review evidence that synaptic neurofilament proteins Dendritic spine Neuropsychiatric disease are a sizable population in the CNS and we advance the concept that changes in the levels or post- translational modification of individual NF subunits contribute to synaptic and behavioral dysfunction in certain neuropsychiatric conditions.
    [Show full text]
  • Internexin Causes Abnormal Neurofilamentous Accumulations
    The Journal of Neuroscience, April 15, 1999, 19(8):2974–2986 Overexpression of a-Internexin Causes Abnormal Neurofilamentous Accumulations and Motor Coordination Deficits in Transgenic Mice Gee Y. Ching,1 Chung-Liang Chien,2 Roberto Flores,1 and Ronald K. H. Liem1 1Departments of Pathology and Anatomy and Cell Biology, Columbia University College of Physicians and Surgeons, New York, New York 10032, and 2Department of Anatomy, National Taiwan University School of Medicine, Taipei, Taiwan 100, Republic of China a-Internexin is the first neuronal intermediate filament (IF) pro- Behavioral tests demonstrate that these mice have a deficit in tein expressed in postmitotic neurons of the developing ner- motor coordination as early as 3 months of age, consistent with vous system. In the adult, its expression is restricted to mature the morphological neuronal changes. Our data further demon- neurons in the CNS. To study the potential role of a-internexin strate that the neurofilamentous inclusions also lead to progres- in neurodegeneration, we have generated transgenic mice that sive loss of neurons in the aged transgenic mice. The motor overexpress rat a-internexin. The total levels of a-internexin coordination deficit and the loss of neurons are transgene expressed in the hemizygous and homozygous transgenic mice dosage-dependent. These data yield direct evidence that high were ;2 and ;3 times the normal level, respectively. Overex- levels of misaccumulated neuronal IFs lead to neuronal dys- pression of a-internexin resulted in the formation of cerebellar function, progressive neurodegeneration, and ultimate loss of torpedoes as early as 1 month of age. These torpedoes are neurons.
    [Show full text]
  • Role of Gigaxonin in the Regulation of Intermediate Filaments: a Study Using Giant Axonal Neuropathy Patient-Derived Induced Pluripotent Stem Cell-Motor Neurons
    Role of Gigaxonin in the Regulation of Intermediate Filaments: a Study Using Giant Axonal Neuropathy Patient-Derived Induced Pluripotent Stem Cell-Motor Neurons Bethany Johnson-Kerner Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy under the Executive Committee of the Graduate School of Arts and Sciences COLUMBIA UNIVERSITY 2013 © 2012 Bethany Johnson-Kerner All rights reserved Abstract Role of Gigaxonin in the Regulation of Intermediate Filaments: a Study Using Giant Axonal Neuropathy Patient-Derived Induced Pluripotent Stem Cell-Motor Neurons Bethany Johnson-Kerner Patients with giant axonal neuropathy (GAN) exhibit loss of motor and sensory function and typically live for less than 30 years. GAN is caused by autosomal recessive mutations leading to low levels of gigaxonin, a ubiquitously-expressed cytoplasmic protein whose cellular roles are poorly understood. GAN pathology is characterized by aggregates of intermediate filaments (IFs) in multiple tissues. Disorganization of the neuronal intermediate filament (nIF) network is a feature of several neurodegenerative disorders, including amyotrophic lateral sclerosis, Parkinson’s disease and axonal Charcot-Marie-Tooth disease. In GAN such changes are often striking: peripheral nerve biopsies show enlarged axons with accumulations of neurofilaments; so called “giant axons.” Interestingly, IFs also accumulate in other cell types in patients. These include desmin in muscle fibers, GFAP (glial fibrillary acidic protein) in astrocytes, and vimentin in multiple cell types including primary cultures of biopsied fibroblasts. These findings suggest that gigaxonin may be a master regulator of IFs, and understanding its function(s) could shed light on GAN as well as the numerous other diseases in which IFs accumulate.
    [Show full text]
  • Analysis of Protein Expression Regulated by Lumican in PANC‑1 Cells Using Shotgun Proteomics
    ONCOLOGY REPORTS 30: 1609-1621, 2013 Analysis of protein expression regulated by lumican in PANC‑1 cells using shotgun proteomics TETSUSHI YAMAMOTO, MITSUHIRO KUDO, WEI-XIA PENG and ZENYA NAITO Departments of Pathology and Integrative Oncological Pathology, Nippon Medical School, Bunkyo-ku, Tokyo 113-8602, Japan Received March 19, 2013; Accepted May 30, 2013 DOI: 10.3892/or.2013.2612 Abstract. Lumican, a member of the class II small leucine- the core protein (1,2). Amino acid sequencing indicates that rich proteoglycan family, regulates the assembly and diameter lumican has 4 potential sites for N-linked keratan sulfate (KS) of collagen fibers in the extracellular matrix of various tissues. or oligosaccharides (3,4). Therefore, lumican includes a core We previously reported that lumican expression in the stromal protein, glycoprotein and proteoglycan forms due to glycosyl- tissues of pancreatic ductal adenocarcinoma (PDAC) correlates ation (5). Lumican is a secreted collagen-binding extracellular with tumor invasion, and tends to correlate with poor prog- matrix protein of the cornea, dermis and tendon stroma, nosis. Lumican stimulates growth and inhibits the invasion of arterial wall, and intestinal submucosa (6-9). Corneal opacity, a PDAC cell line. In the present study, we performed a global as well as skin and tendon fragility due to disorganized and shotgun proteomic analysis using lumican-overexpressing loosely packed collagen fibers in lumican-null mice suggest PANC-1 cells and lumican downregulated PANC-1 cells to that lumican plays an important role in collagen fibrillogen- identify candidate proteins that are regulated by lumican and esis (10,11). related to cell growth and invasion in PDAC cells.
    [Show full text]